Publications

Export 22 results:
Sort by: Author Title Type [ Year (Desc)]
2024
Madbouly, N., A. Ooda, A. Nabil, A. Nasser, E. Ahmed, F. Ali, F. Mohamed, H. Faried, M. Badran, M. Ahmed, et al., "The renoprotective activity of amikacin–gamma-amino butyric acid–chitosan nanoparticles: a comparative study", Inflammopharmacology, 2024.
2023
Farid, A., L. El-Alfy, and N. Madbouly, "Bone marrow-derived mesenchymal stem cells transplantation downregulates pancreatic NF-κB and pro-inflammatory cytokine profile in rats with type I and type II-induced diabetes: a comparison study", Biologia, vol. 78, pp. 3165–3177, 2023.
Farid, A., A. Ooda, A. Nabil, A. Nasser, E. Ahmed, F. Ali, F. Mohamed, H. Farid, M. Badran, M. Ahmed, et al., "Eobania vermiculata whole-body muscle extract-loaded chitosan nanoparticles enhanced skin regeneration and decreased pro-inflammatory cytokines in vivo", Journal of Nanobiotechnology , vol. 21, issue 373, pp. 1-23, 2023.
2022
Shater, H., M. Fawzy, A. Farid, A. El-Amir, S. Fouad, and N. Madbouly, "B-cell activating factor and A proliferation-inducing ligand in relation to intima-media thickness as biomarkers of premature atherosclerosis in systemic lupus erythematosus patients", The American Journal of the Medical Sciences, vol. 364 , issue 5, pp. 646-654, 2022.
Shater, H., M. Fawzy, A. Farid, A. El-Amir, S. Fouad, and N. Madbouly, "B-cell activating factor and a proliferation-inducing ligand in relation to intima-media thickness as biomarkers of premature atherosclerosis in systemic lupus erythematosus …", The American Journal of the Medical Sciences, vol. 2022, 2022.
Madbouly, N. A., G. El-Hadad, and A. A. Farid, "Hazard effects of chronic consumption of sucralose and saccharin-sodium cyclamate mixture in murine model", Egyptian Journal of Chemistry, vol. 65, issue 5, 2022.
El-Hadad, G., A. A. Farid, A. M. El Amir, and N. A. Madbouly, "Hazard effects of chronic consumption of sucralose and saccharin-sodium cyclamate mixture in murine model", Egyptian Journal of Chemistry, vol. 65, issue 5, pp. 279-289, 2022.
Madbouly, N. A., M. Emam, M. Ayman, M. Ayman, I. Rabia, and A. E. Amir, "In vitro and in vivo impacts of nifedipine and diltiazem on praziquantel chemotherapy in murine Schistosoma mansoni", Experimental Parasitology, vol. 236, pp. 108256, 2022.
Madbouly, N. A., M. Emam, M. Ayman, M. Ayman, I. Rabia, and E. A. Amir, "In vitro and in vivo impacts of nifedipine and diltiazem on praziquantel chemotherapy in murine Schistosoma mansoni", Experimental Parasitology, vol. 236, pp. 108256, 2022.
Shater, H., M. Fawzy, A. Farid, A. El-Amir, S. Fouad, and N. Madbouly, "The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family", Lupus, vol. 31, issue 1, pp. 55-64, 2022.
Shater, H., M. Fawzy, A. Farid, A. El-Amir, S. Fouad, and N. Madbouly, "The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family", Lupus , vol. 31, issue 1, pp. 55-64, 2022.
2021
Madbouly, N. A., and A. Z. Z. A. E. L. M. AMIR, "ARTESUNATE COMBINED WITH PRAZIQUANTEL THERAPY MODULATE THE ANTIBODY RESPONSE IN MURINE SCHISTOSOMIASIS MANSONI", Journal of the Egyptian Society of Parasitology, vol. 51, issue 3, pp. 443-450, 2021.
Madbouly, N., A. E. Amir, A. Abd El Kader, I. Rabee, and A. Farid, "The immunomodulatory activity of secnidazole–nitazoxanide in a murine cryptosporidiosis model", Journal of Medical Microbiology, vol. 70, issue 3, pp. 001327, 2021.
Madbouly, N., A. Azmy, A. Salama, and A. El-Amir, "The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation", The Journal of Antibiotics, vol. 74, issue 9, pp. 580-592, 2021.
2020
Madbouly, N. A., H. Nashee, A. A. Elgendy, I. Rabee, and A. E. Amir, "Encapsulation of Low Metronidazole Dose in Poly (D, L-lactide-co-glycolide)(PLGA) Nanoparticles Improves Giardia intestinalis Treatment", Infection & chemotherapy, vol. 52, issue 4, pp. 550, 2020.
Madbouly, N. A., H. Nashee, A. A. Elgendy, I. Rabee, and A. E. Amir, "Encapsulation of Low Metronidazole Dose in Poly (D, L-lactide-co-glycolide)(PLGA) Nanoparticles Improves Giardia intestinalis Treatment", Infection & chemotherapy, vol. 52, issue 4, pp. 550, 2020.
Madbouly, N. A., D. O. A. A. A. MOHAMED, I. B. R. A. H. E. E. M. R. BAUIOMY, and A. Z. Z. A. E. L. M. AMIR, "IMMUNOLOCALIZATION OF EXCRETORY/SECRETORY ANTIGENS EXPRESSED ON DIFFERENT LIFE CYCLE STAGES AND IN DIFFERENT ORGANS OF FASCIOLA GIGANTICA INFECTED CATTLE", Journal of the Egyptian Society of Parasitology, vol. 50, issue 3, pp. 580-589, 2020.
2016
Adel, N., A. Farid, A. El-Badry, and A. E. Amir, "IMMUNE-MOLECULAR IDENTIFICATION OF GIARDIA INTESTINALIS IN DIARRHOEAL CHILDREN: COMPARISON OF THREE DIAGNOSTIC METHODS", THE EGYPTIAN SOCIETY OF PARASITOLOGY, vol. 46, issue 2, pp. 253-260, 2016.
Madbouly, N., A. Farid, A. A. El-Badry, and A. M. El-Amir, "Prevalence and risk factors of Giardia intestinalis in symptomatic and asymptomatic children in Egypt", THE EGYPTIAN SOCIETY OF PARASITOLOGY, 2016. Abstract

A cross-sectional study was conducted to determine the prevalence and to identify the risk factors associated with Giardia intestinalis in diarrhoeal and non-diarrhoeal children attending outpatient clinic in Children’s University Hospital in Munira (Abu a Reesh Hospital) Kasr Al Ainy, School of Medicine, Cairo University, Egypt. A total of 200 children participated in the study of which 100 (50%) were symptomatic and 100 (50%) were asymptomatic. In diarrhoeal children, the prevalence of G. intestinalis was 8% by direct examination and increased to 26% when n-PCR targeting beta giardin (bg) was applied. In healthy children, prevalence was 7% using n-PCR as diagnostic tool. A significant difference was recorded in frequency of G. intestinalis identification from the stools of symptomatic children than that of children who were asymptomatic. No significant association was observed between infection of giardiasis and gender in both symptomatic and asymptomatic groups. Children aging (4-8 years) was found to be at high risk of acquiring asymptomatic giardiasis (odds ratio (OR) = 8.14, 95% confidence interval (CI) = 0.93-71.50). Contact to animals was shown to be associated risk factor G. intestinalis infection in both symptomatic (OR= 2.46, 95% CI= 0.93- 6.50) and asymptomatic (OR= 7.61, 95% CI= 1.38-41.90) children.

2015
Madbouly, N. A., I. R. Shalash, S. E. O. Deeb, and A. E. M. Amira, "Effect of artemether on cytokine profile and egg induced pathology in murine schistosomiasis mansoni", Journal of Advanced Research, 2015. Abstract

Artemether (ART), the methylated derivative of artemisinin, is an efficacious antimalarial drug
that also displays antischistosomal properties. This study was designed to evaluate the immunomodulatory
action of a single intramuscular dose (50 mg/kg body weight) of ART in comparison
with PZQ treatment (42 days PI). ART administration was 7, 14, 21 and 45 days PI. ART
effect was studied parasitologically, histopathologically and immunologically. It was found that
maximum effect was reached when ART treatment interfered with 14 or 21 days old schistosomula.
ART treatment 14 or 21 days PI was associated with shift from Th2 to Th1 predominancy
(decrease in IL-4 and upgrading of serum IFN-c levels). In conclusion, ART is a promising drug
in control of schistosomiasis mansoni due to its reductive effect on worm burden and its role in
improvement of hepatic granulomatous lesions.

Madbouly, N., A. E. Amir, and S. E. Deeb, Evaluation of the immunomodulatory efficacy of artemether, : Scholar's Press, 2015.
2010
Madbouly, N. A., Evaluation of the Immunomodulatory Efficacy of Artemether in the Protection against Schistosoma Mansoni Infection In Albino Mice, , Giza, Cairo University, 2010.
Tourism